ABOUT CITELINE
Citeline powers a full suite of complementary business intelligence offerings to meet the evolving needs of health care professionals to accelerate the connection of treatments to patients and patients to treatments. These patient-focused solutions and services deliver and analyze data used to drive clinical, commercial and regulatory-related decisions and create real-world opportunities for growth.
Our global teams of analysts, journalists and consultants keep their fingers on the pulse of the pharmaceutical, biomedical and medtech industries, covering it all with expert insights: key diseases, clinical trials, drug R&D and approvals, market forecasts and more.
FEATURED CONTENT
-
With the rising complexity of trials and dwindling site availability, the adoption of backup sites has become increasingly commonplace, reflecting the industry's commitment to maximizing recruitment potential.
-
As we reflect on the past year's accomplishments and challenges, our insights serve as a beacon for driving innovation, fostering collaboration, and advancing global healthcare outcomes.
-
Recent FDA emphasis on plain language underscores a shift towards greater transparency and patient understanding, highlighted in the joint FDA and Office for Human Research Protections (OHRP) draft guidance.
-
Discover why achieving true diversity demands more than rhetoric—requiring genuine engagement, cultural humility, and a commitment to understanding and addressing the unique needs of marginalized communities.
-
Sessions at SCOPE ran the industry gamut: patient-centric trial design; diversity, equity, and inclusion; AI; RWE; and much more. The common thread woven through many of these sessions? Quality data.
-
Review the FDA's revised 2016 diversity guidance, which establishes clear expectations and standardizes recommendations for gathering and reporting race and ethnicity data.
-
Uncover how a global pharmaceutical company seeking to identify promising indications among rare diseases to develop preclinical candidate molecules received an in-depth disease analysis to guide its strategic decision-making.
-
Pharma and biotech companies prioritize innovation in areas of high and rare unmet need. Though the R&D landscape for these rare diseases can be difficult to navigate, changes are on the horizon.
-
Learn how sponsors can address the challenge of submitting clinical trial data in a consistent and compliant manner by examining internal processes to identify and close gaps.
-
As the availability of RWD grows, it creates opportunities for sponsors to use true patient insights to support their clinical strategy and bring treatments to patients in need.
-
DCTs, RWD, IRA … our industry predictions for 2024 are filled with acronyms. As we delve into 2024, explore what trends are hot ― and not ― for the coming year, and their impact on the industry.
-
Explore how Rezolute was able to overcome challenges while recruiting pediatric patients for a Congenital Hyperinsulinism (HI) clinical trial using a streamlined, single-source tool.
-
Experts from Genentech, Moderna, and Patientory share how collaborative approaches involving technology and multiple resources can improve health outcomes and increase diversity in clinical trials.
-
Read about how this workshop served as a reminder of the need for diversity in patient recruitment and the shared commitment across the spectrum of clinical trial stakeholders.
-
Consider this proactive approach to patient recruitment that has the potential to ensure a more dynamic and responsive strategy, and is suited for the rapidly changing landscape of clinical trials.
-
Discover how Sitetrove empowers teams to access patient insights, including age, race, and gender demographics, at various levels such as state, city, investigator, and primary organization.
-
Predicting the future in the biopharma realm is inherently challenging. Read this report for insights into the evolving dynamics of the healthcare and biopharma sectors in the coming year.
-
Learn how sponsors can transform compliance functions into unique strengths, not only meeting regulatory requirements but also uncovering strategic opportunities in this challenging landscape.
-
Learn how to gauge success by addressing the challenges that patient engagement and recruitment places on sites, as well as patients.
-
Explore the dynamics behind interesting and sometimes precedent-setting new drug approvals and uncover how the regulatory process works in practice.
CONTACT INFORMATION
Citeline
605 Third Ave.
New York, NY 10158
UNITED STATES
Phone: 1 212-600-3530
Contact: Steven Horlock
FEATURED SOLUTIONS
- Introducing Citeline PatientMatch: Precision Patient Recruitment
- Lab Alerts: Target Relevant Patients For Clinical Trials
- Accelerated Clinical Trial Disclosure Starts Here
- Expanding Enrollment Reach And Accelerating Timelines
- Global News And Expert Analysis On Pharma Policy And Regulation
- Accelerating Patient Engagement And Recruitment
- Mastering Multi-Channel, Multi-Vendor Clinical Trial Recruitment
- Educate, Engage, Enroll: Accelerating Patient Recruitment
- Finally, An End-To-End Patient Recruitment Platform
- Connecting The Dots For Patient Recruitment
- How The Sitetrove Diversity Module Can Diversify Studies
- Revolutionizing Engagement, Education, & Enrollment Across Clinical Portfolios
- Citeline’s Pharmaprojects & Biomedtracker Solution
- TrialScope Intelligence Disclosure Regulatory Tracking
- Widen The Trial Recruitment Funnel, Streamline Engagement, & Enrollment
FEATURED WEBINARS
-
Compliance is more important than ever. Keep up with how regions are enforcing disclosure requirements by learning how to adjust compliance strategies accordingly.
-
Taken from a spotlight session at the CNS Summit, gain insights from thought leaders from Norstella and Citeline regarding artificial intelligence and real-world data.
-
Consider this diverse range of real-world perspectives, complemented by data-driven insights, when looking to enhance the speed, accessibility, and efficiency of clinical trial processes.
-
Listen in as industry leaders discuss how to meet the needs of multiple stakeholders while ensuring operational efficiency, study success, and enterprise scale.
-
See the results of a joint survey with 1nHealth on how compensation is likely to impact participation in clinical trials, followed by a thought-provoking roundtable on this timely topic.
-
In this webinar, discover the trends shaping pharma’s R&D pipeline, with data broken down by therapeutic area, disease, mechanism and target, and drug type.
-
Now that the EU’s Clinical Trials Information System (CTIS) is up and running, disclosure and transparency experts from Sarepta, Boehringer Ingelheim, Bayer and Merck KgaA discuss the ins and outs of registering clinical trials and submitting study information to the portal.
-
Disclosure experts Thomas Wicks and Francine Lane explain the importance of consistency and creating a disclosure template, plain language summaries source documents, and authoring with redaction in mind.
-
In this informative webinar, clinical trial disclosure experts Francine Lane and Thomas Wicks provide a high-level overview of EU CTR/CTIS regulations, show how they differ from the EU CTD directive, share timelines for compliance, and discuss the scope of data sharing.
-
In this presentation delivered at SCOPE 2022, hear how ICON leveraged Study Feasibility to its advantage.